The store will not work correctly when cookies are disabled.
4-Acetamido-5-(2-methylbutanamido)-2-fluoro benzoic acid
ID: ALA560987
PubChem CID: 45269200
Max Phase: Preclinical
Molecular Formula: C14H17FN2O4
Molecular Weight: 296.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCC(C)C(=O)Nc1cc(C(=O)O)c(F)cc1NC(C)=O
Standard InChI: InChI=1S/C14H17FN2O4/c1-4-7(2)13(19)17-11-5-9(14(20)21)10(15)6-12(11)16-8(3)18/h5-7H,4H2,1-3H3,(H,16,18)(H,17,19)(H,20,21)
Standard InChI Key: TVKITEIFJSVNMU-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 21 0 0 0 0 0 0 0 0999 V2000
4.8470 -11.9200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5615 -12.3325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2759 -11.9200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2759 -11.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5615 -10.6825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8470 -11.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1325 -10.6825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4180 -11.0950 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1325 -9.8575 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1325 -12.3325 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.9904 -12.3325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9904 -13.1575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7049 -13.5700 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2759 -13.5700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9904 -10.6825 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7049 -11.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7049 -11.9200 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4193 -10.6825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1338 -11.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1338 -11.9200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4193 -9.8575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 11 1 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
12 14 1 0
6 7 1 0
4 15 1 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
16 18 1 0
7 9 2 0
18 19 1 0
4 5 1 0
19 20 1 0
1 10 1 0
18 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.30 | Molecular Weight (Monoisotopic): 296.1172 | AlogP: 2.47 | #Rotatable Bonds: 5 |
Polar Surface Area: 95.50 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.25 | CX Basic pKa: ┄ | CX LogP: 1.94 | CX LogD: -1.50 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.78 | Np Likeness Score: -0.94 |
References
1. Magesh S, Savita V, Moriya S, Suzuki T, Miyagi T, Ishida H, Kiso M.. (2009) Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids., 17 (13): [PMID:19450982] [10.1016/j.bmc.2009.04.065] |